Launching a new orthopedic product is already complex. Packaging shouldn’t make it harder.
As OEMs expand their portfolios, a product-by-product approach to sterile packaging can create unnecessary complexity. Different formats can mean different component suppliers, validation requirements, equipment, and processes to manage.
A standardized packaging platform offers another approach: establish a standardized, flexible foundation that can support today’s products while making it easier to adopt and launch what comes next.
Moving Beyond One-Off Packaging Decisions
Packaging is often selected for an immediate need. A new implant enters development, a packaging solution is created, and the product moves toward commercialization.
Repeat that process across multiple product families, however, and complexity can grow quickly.
For OEMs planning portfolio expansion, packaging strategy should consider more than the next launch. The question becomes: Can the packaging platform scale as new products are introduced?
Guardian Medical customers have demonstrated how this can work in practice. Once CapSure™ is established as part of their sterile packaging strategy, the platform can be adapted to accommodate additional products, implant sizes, and configurations. CapSure™ can work with a range of implant holder types and materials, giving OEMs a flexible foundation for portfolio growth.
Instead of reinventing the packaging process with every new product, teams can build on a system they already know.
Creating a More Efficient Path to Launch
Standardization can be particularly valuable during commercialization.
Traditional sterile packaging may require sealing equipment, equipment validation, seal verification, and ongoing testing. CapSure™ requires no sealing equipment to purchase, validate, or maintain. Its pre-validated seal with a 10-year shelf life can be adopted to reduce or eliminate certain aspects of sterile packaging design and validation.
For R&D and quality teams, this can reduce the resources required to establish a sterile packaging supply chain. For operations, it means fewer suppliers, equipment, materials, and processes to manage.
As additional products enter the portfolio, OEMs can continue working within a uniform packaging platform rather than introducing an entirely new approach with each launch.
Consistency From Operations to the OR
The advantages of standardization continue throughout the product lifecycle.
CapSure™ reduces package size, weight, and, in many instances, the number of packaging components required. That results in improved efficiency across sterilization, shipping, storage, and inventory management. Its 10-year validated shelf life also helps OEMs manage less frequently used implant sizes and reduce the risk of expired inventory write-offs.
Standardization can also create a more consistent experience in the OR.
With anywhere from 30 to 400 implants potentially available during an orthopedic procedure, rapid identification and retrieval matter. CapSure™ uses transparent packaging and color- and size-coded tamper labels to help surgical teams quickly identify and verify implants, while its intuitive opening supports reliable usability and aseptic transfer.
As new product families are added, maintaining that familiar experience can make the entire portfolio easier to navigate.
Build for the Next Launch, Too
Packaging standardization is about more than creating consistency. It’s about building a foundation for growth.
A flexible packaging platform can help OEMs simplify future product introductions, reduce operational complexity, and create a consistent end user experience across product families.
The sterile packaging decision made for one product can make the next launch easier.
As your portfolio grows, your packaging strategy should be ready to grow with it. Connect with Guardian Medical's experts to learn how CapSure™ can provide a flexible foundation for your next product launch and beyond.
